Table 1.
Characteristics of the participants, anthropometrics, muscular fitness, clinical and metabolic biomarkers, LMCRI and CMRSI by BMI
| Characteristics of the participants | BMI Groups | ||
|---|---|---|---|
| All participants (n = 6,095) | BMI Normal (n = 4,814) | BMI OW/OB (n = 1,281) | |
| Age (years) | 29.6 ± 11.7 | 25.1 ± 9.3 | 36.1 ± 11.8* |
| Smoking n, (%) | 803 (13.1) | 604 (12.5) | 199 (15.5) |
| BM (kg) | 62.3 ± 11.8 | 58.2 ± 8.3 | 76.1 ± 11.3* |
| Height (m) | 1.65 ± 0.1 | 1.65 ± 0.09 | 1.66 ± 0.09* |
| BMI (kg•m−1) | 22.8 ± 3.4 | 21.3 ± 2.0 | 27.6 ± 2.6* |
| WC (cm) | 81.0 ± 11.8 | 75.3 ± 6.8 | 92.7 ± 11.4* |
| SBP (mmHg) | 114.0 ± 14.0 | 112.7 ± 13.5 | 118.9 ± 14.7* |
| DBP (mmHg) | 70.0 ± 10.0 | 69.3 ± 9.9 | 72.9 ± 10.0* |
| MBP (mmHg) | 85.8 ± 9.6 | 85.8 ± 9.6 | 85.9 ± 9.6 |
| MF (kg) | 29.9 ± 10.3 | 29.4 ± 10.1 | 32.1 ± 11.0* |
| MF / BM (kg) | 0.494 ± 0.189 | 0.508 ± 0.191 | 0.444 ± 0.175* |
| Total cholesterol (mg/dL) | 165.4 ± 44.6 | 155.4 ± 38.4 | 185.8 ± 49.0* |
| Triglycerides (mg/dL) | 114.9 ± 80.7 | 89.2 ± 45.4 | 168.1 ± 107.0* |
| LDL-c (mg/dL) | 92.5 ± 34.4 | 86.7 ± 28.3 | 105.3 ± 42.9* |
| HDL-c (mg/dL) | 47.7 ± 16.8 | 49.1 ± 18.3 | 44.4 ± 12.0* |
| Glucose (mg/dL) | 80.3 ± 13.6 | 77.3 ± 12.2 | 86.1 ± 14.2* |
| LMCRI | 0.167 ± 1.337 | −0.291 ± 0.841 | 1.127 ± 1.644* |
| CMRSI | −1.064 ± 0.369 | −1.102 ± 0.365 | −0.899 ± 0.343* |
Mean ± standard deviation. ANOVA test was used to examine any significant difference by BMI group
OW/OB overweight/obese; BM body mass; BMI body mass index; WC waist circumference; SBP systolic blood pressure; DBP diastolic blood pressure; MBP Mean blood pressure; MF muscular fitness; LMCRI lipid–metabolic cardiovascular risk index; CMRSI Cardiometabolic Risk Factor Score Index
* Differences between normal and overweight/obese BMI groups (P < 0.001)